Boothbay Fund Management’s Astera Labs ALAB Stock Holding History

Boothbay Fund Management’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-22,800	Closed	-$3.79M	–	2539
2025 Q4	$3.79M	Buy	+22,800	New	+$3.81M	0.06%	373

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Boothbay Fund Management's ALAB Position: Q2 2026 in Review

Boothbay Fund Management sold out of Astera Labs (ALAB) in Q2 2026, closing a stake of 6,526 shares — an estimated $715K sold.

Boothbay Fund Management first reported a position in ALAB in Q1 2024 and held it in 8 quarters. The position peaked at $7.32M in Q4 2025. 993 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Boothbay Fund Management reported no remaining Astera Labs position as of Q2 2026 after selling out during the quarter.
Boothbay Fund Management sold 6,526 Astera Labs shares in Q2 2026, an estimated $715K.
Boothbay Fund Management first reported a position in Astera Labs in Q1 2024 and held it in 8 quarters.
Boothbay Fund Management's Astera Labs position peaked at $7.32M in Q4 2025.
993 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.